Interstitial Lung Disease: Breathing Effects and Management

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on genetics & lung health. Browse all Genetics & Lung Health education

Interstitial lung disease (ILD) is not a single illness but a family of more than 200 conditions that share one feature: scarring or inflammation in the interstitium, the delicate tissue that surrounds the air sacs of the lungs. As that tissue stiffens, the lungs lose the flexibility they need to move oxygen efficiently. This article covers what that means for breathing, how ILD is followed over time, and where inherited biology fits into the picture.

How ILD changes breathing

The air sacs, or alveoli, depend on thin, elastic walls to pass oxygen into the bloodstream. In ILD, those walls thicken and scar, so gas exchange becomes less efficient and the lungs expand less easily with each breath. The earliest and most common consequence is breathlessness on exertion — climbing stairs, walking uphill — followed by a persistent dry cough. Over time, some people notice fatigue, unintended weight loss, or clubbing of the fingertips.

Why the consequences build gradually

Because scarring accumulates slowly, many people adapt without realizing it, avoiding the activities that leave them short of breath. That gradual accommodation is part of why ILD is often recognized later than it could be. As lung volumes fall, the heart can be affected too: the right side of the heart works harder to push blood through stiffened lungs, a strain that clinicians watch for.

How ILD is monitored and managed

There is no single test that captures ILD. Clinicians combine high-resolution CT imaging, pulmonary function tests that measure lung volume and gas transfer, and sometimes tissue sampling to characterize the pattern. Management is individualized and always physician-led. Depending on the subtype and cause, it can include treating an underlying condition, pulmonary rehabilitation to build exercise tolerance, supplemental oxygen, vaccination to prevent respiratory infections, and smoking cessation. The goal is to preserve function and quality of life, and decisions belong with a pulmonologist who knows the specific diagnosis.

The genetic layer in pulmonary fibrosis

Some forms of ILD, especially idiopathic pulmonary fibrosis, have a well-documented inherited component. The single most studied variant is a common change in the promoter of the MUC5B gene, rs35705950. MUC5B encodes a mucin that helps clear the airways; the rs35705950 variant is the strongest known genetic risk factor for pulmonary fibrosis, present in a substantial share of cases even though it is also carried by many healthy people. It shifts baseline risk — it does not, by itself, cause the disease.

A second important pathway involves telomeres, the protective caps on the ends of chromosomes. Variants in TERT and related telomere-maintenance genes are linked to shorter telomeres and to familial forms of pulmonary fibrosis. These findings illustrate a broader theme: several distinct biological pathways — mucus clearance, cellular aging, surfactant production — converge on lung tissue vulnerability.

Where genetic insight fits

Knowing about pathways connected to tissue repair, cellular aging, and inflammation adds context, not certainty. Genetics is a guide, not a guarantee, and it never stands in for pulmonary function testing or a specialist's evaluation. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, giving pathway-level education about the biology behind processes such as inflammation and cellular aging. It does not diagnose, treat, or manage interstitial lung disease; it offers informed background you can bring to a conversation with your provider.

Frequently Asked Questions About Interstitial Lung Disease

What is the first sign of interstitial lung disease?

Shortness of breath during exertion is usually the earliest sign, often paired with a persistent dry cough. Because these develop gradually, many people adjust their activity without noticing the change. New or worsening breathlessness that does not resolve deserves evaluation by a healthcare provider, ideally a pulmonologist.

Can interstitial lung disease be reversed?

Scarring from ILD is generally not reversible, but not all ILD is progressive, and management can preserve function and quality of life. Inflammatory forms may respond to treating the underlying cause. Approaches such as pulmonary rehabilitation, oxygen, and infection prevention are decided by a specialist based on the specific subtype.

Is interstitial lung disease genetic?

Some forms carry inherited risk. The MUC5B variant rs35705950 is the strongest known genetic risk factor for pulmonary fibrosis, and telomere genes such as TERT are linked to familial cases. These variants shift baseline risk rather than guaranteeing disease, and most people who carry them never develop ILD.

Does a genetic test diagnose ILD?

No. Genetic testing describes pathway-level tendencies — for example in inflammation or cellular aging — not a diagnosis. ILD is identified through imaging, pulmonary function tests, and specialist evaluation. Genetic context can inform a broader conversation with your provider, but it never replaces clinical assessment or lung-function monitoring.

Curious how your genetics fit into the bigger picture? Explore the Precision Peptide Genetic Test for pathway-level insight you can bring to a conversation with your healthcare provider.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, cure, manage, or prevent any medical condition. Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your care.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

This article is part of the PlexusDx Education Hub. Browse all Genetics & Lung Health education